Antiplatelet Therapy in a Patient with Coronary Artery Disease and Myelodysplastic Syndrome with Thrombocytopenia Cited by

Acta Medica > Archive > 2017, Vol. 60 > Issue 2 > p. 82 > Cited by

Acta Med. 2017, 60: 82-84

https://doi.org/10.14712/18059694.2017.98

Antiplatelet Therapy in a Patient with Coronary Artery Disease and Myelodysplastic Syndrome with Thrombocytopenia

Francisco José Fernández-Fernández^a, Eugenia Ameneiros-Lago^a, Cintia Tuñas-Gesto^b, Inmaculada Gómez-Buela^a

^aDepartment of Internal Medicine, Complejo Hospitalario Universitario de Ferrol, Ferrol 15405, Spain
^bSection of Neurology, Complejo Hospitalario Universitario de Ferrol, Ferrol 15405, Spain

Received March 30, 2017
Accepted May 23, 2017

Crossref Cited-by Linking

Long Manyun, Ye Ziliang, Zheng Jing, Chen Wuxian, Li Lang: Dual anti-platelet therapy following percutaneous coronary intervention in a population of patients with thrombocytopenia at baseline: a meta-analysis. BMC Pharmacol Toxicol 2020, 21. <https://doi.org/10.1186/s40360-020-00409-2>
Aspirin/ticagrelor. Reactions Weekly 2018, 1708, 63. <https://doi.org/10.1007/s40278-018-48156-y>

Acta MedicaJournal of Faculty of Medicine in Hradec Králové

Acta Med. 2017, 60: 82-84

Antiplatelet Therapy in a Patient with Coronary Artery Disease and Myelodysplastic Syndrome with Thrombocytopenia

Crossref Cited-by Linking

Acta Medica
Journal of Faculty of Medicine in Hradec Králové